Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection

Fig. 2

The evaluation value of CRC patients and screening of subjects. The evaluation value of CRC patients was significantly higher than those of AA, NA, healthy controls, and other cancer patients. The evaluation value of AA and NA patients were significantly higher than those in healthy controls. No significant differences were seen between AA and NA patients, other cancer patients, and healthy controls

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us